Psychotic Disorders, 1st Edition
A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments.
These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis. But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders.
The chapter authors expertly detail the data supporting this innovative approach. They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options. Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders.
This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder.
A counterintuitive and novel approach to the long-sought goal of subtyping schizophrenia and other psychotic disorders emerges from ongoing research. Five psychosis associated anxiety and depressive subtypes each help define five corresponding psychosis diagnoses, their fixed false beliefs, and most importantly, their treatments.
These anxiety and depressive comorbidities have long been long overlooked as an understandable hodgepodge of distressing symptoms caused by the pain of psychosis. But these five comorbidities usually precede onset of the psychosis, and their treatment can significantly improve outcome. So, maybe, the causation is the other way around: maybe they are among the underlying contributors to schizophrenia and other psychotic disorders.
The chapter authors expertly detail the data supporting this innovative approach. They provide fictional case studies, DSM-5 diagnostic criteria, specific interviewing approaches for the five comorbidities in psychosis patients, and improved treatment options. Other chapters explore psychoses related to substance use, medical illness and medical treatment, as well as other factors that contribute to psychotic disorders.
This first-of-its-kind reference is a valuable clinical, educational, research and training resource for psychiatrists, psychologists, nurses, social workers, neurologists and anyone interested in the care and treatment of someone with a psychotic disorder.
Key Features
-
Reflects current research, diagnosis, and treatment options for:
-
Schizophrenia with Voices and Panic Anxiety
-
Obsessive-Compulsive Schizophrenia and Obsessive-Compulsive Disorder
-
Persecutory Delusional Disorder and Social Anxiety
-
Delusional Depression and Melancholic Depression
-
Bipolar I Disorder and Atypical Depression
-
Substance Use Psychoses
-
Medical Illness and Iatrogenic Psychoses
-
Covers treatment options and outcomes with medication and psychotherapy.
-
Includes sample patient interview approaches and/or biological tests for each diagnosis.
-
Highlights symptoms, quasi-psychotic symptoms and secondary signs of the comorbidities when alone, and when in conjunction with psychosis.
-
Reviews diagnosis-specific significance and contributory roles of neurotransmitters, hypofrontality, psychological trauma, and genetics.
-
Enhanced eBook version allows access to entire book contents on most devices. Included free with book purchase, or purchase separately.
Author Information
| ISBN Number | 9780323683098 |
|---|---|
| Description Author List | Edited by André Barciela Veras, MD, PhD, Department of Psychiatry, University of the State of Mato Grosso do Sul, Campo Grande – MS, Brazil and Jeffrey P. Kahn, MD, Weill-Cornell Medical College, New York, New York |
| Copyright Year | 2021 |
| Edition Number | 1 |
| Format | Book |
| Trim | 152w x 229h (6.00" x 9.00") |
| Imprint | Saunders |
| Page Count | 148 |
| Publication Date | 4 Dec 2020 |
| Stock Status | Please allow 3-4 weeks for delivery |
eBooks : Built for busy schedules & tailored for your goals.
Affordable knowledge, built for you
Get the resources you need-often at a lower cost than print. Quality content designed to support your goals, without stretching your budget.
Seamless access wherever you are
Always in sync
Tools the make learning stick
Your eBook is ready whenever you are!
1. Check your email for your access code.
2. Sign into or create your VitalSource account and redeem your code.
3. Open your eBook - ready whenever you are!
FAQ
The access code for your new eBook will be sent in your order confirmation email. Your code can also be accessed in your My Account section on the Elsevier webshop. If you do not receive your code within a few minutes, please check your spam folder.
Step-by-step guidance on how to download Bookshelf and also redeem your code can be found here.
The access code for your new eBook does not expire. However, we always suggest redeeming immediately after purchase to start experiencing the benefits of and insights from your purchase. Important to note - the code provided is a single use code and only valid for the edition you purchase. It does not provide access to past nor future editions of the title.
You will have unlimited access to your eBook on the device to which it was downloaded.
Discover the various learning features that our eBooks offer on the Bookshelf® Reader! For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information on the learning functions can be found on the Vitalsource page.
Quality is our top priority. That's why we collaborate with the leading eBook reader provider VitalSource. VitalSource has its own eBook reader Bookshelf®, which you can easily download. This reader is very user-friendly and offers more features than other standard readers. For example, you can highlight different text passages, create notes and flashcards, have the text read to you, etc. Particularly practical: You can also use your eBooks offline. More information can be found on the Vitalsource page.
Elsevier offers its eBooks in ePub format, as we believe this format is best suited to display our content ideally on as many devices as possible.
You can return your eBook within 13 days of purchase. eBooks that have been partially printed or flipped through more than 15% are excluded from returns.
Any questions ?
Top Picks from Our Community
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
E-Book
1. Introduction
2. Psychotogenesis Overview
3. Diagnosis: OCD/Schizo-Obsessive
4. Diagnosis: Panic/Panic Psychosis
5. Diagnosis: Social Anxiety/Delusional Disorder
6. Diagnosis: Melancholia/Delusional Depression
7. Diagnosis: Atypical Depression/Mania
8. Diagnosis: Substance Abuse Psychosis
"The editors have organized the text around a remarkable concept that five psychoses account for much of functional psychotic disorders. These five psychotic disorders have common causal factors that contribute to psychosis proneness. Three of these psychoses are already well recognized, and all five appear to be associated with a specific anxiety or depressive disorder. All this implies that neuroleptic treatment, when combined with properly specific anxiety and depression treatment, can make patients much better than with neuroleptics alone. Both editors have contributed to the supporting literature, but there is also a fascinating agenda for further research to explore and expand these concepts. When further documented by additional research, these diagnoses and treatments could have effects on psychotic disorder diagnosis and treatment that could be exceptional, if not ground-breaking. This is clearly a book that needs careful attention in a review, and a wide mental health audience." -- Ira D. Glick, M.D., Professor Emeritus of Psychiatry & Behavioral Sciences, Department of Psychiatry, Stanford University School of Medicine
" Anxiety disorders have suffered relative neglect by psychiatry and psychopharmacology over the past several decades. Drs. Veras and Kahn have done the field a great service by putting together a volume that highlights the important overlap of these disorders, not just with mood disorders, but with schizophrenia spectrum illness as well. Psychotic Disorders will serve as a useful reminder of these under-appreciated comorbidities, in the service of more meaningful classification of psychoses and more effective treatment of those suffering from them." -- Edward Silberman, Professor of Psychiatry, Tufts University School of Medicine
